Bradley D. Gelfand

4.2k total citations · 1 hit paper
39 papers, 1.7k citations indexed

About

Bradley D. Gelfand is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Bradley D. Gelfand has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Ophthalmology, 17 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Bradley D. Gelfand's work include Retinal Diseases and Treatments (18 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Bradley D. Gelfand is often cited by papers focused on Retinal Diseases and Treatments (18 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Bradley D. Gelfand collaborates with scholars based in United States, Japan and India. Bradley D. Gelfand's co-authors include Jayakrishna Ambati, John P. Atkinson, Brett R. Blackman, Ryan E. Feaver, Benjamin J. Fowler, Martin A. Schwartz, Nagaraj Kerur, Yoshio Hirano, Valeria Tarallo and Reo Yasuma and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Bradley D. Gelfand

39 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunology of age-related macular degeneration

2013 482 citations Jayakrishna Ambati, Bradley D. Gelfand et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bradley D. Gelfand United States	18	811	725	359	291	175	39	1.7k
Benjamin J. Fowler United States	14	827 1.0×	847 1.2×	230 0.6×	360 1.2×	126 0.7×	32	1.7k
Jikui Shen United States	33	1.7k 2.1×	1.3k 1.8×	207 0.6×	626 2.2×	143 0.8×	59	2.7k
Yedi Zhou China	22	687 0.8×	627 0.9×	269 0.7×	372 1.3×	165 0.9×	70	1.5k
Jean‐Pierre Faure France	28	925 1.1×	678 0.9×	429 1.2×	255 0.9×	55 0.3×	110	2.3k
Jason Comander United States	21	1.3k 1.5×	386 0.5×	228 0.6×	195 0.7×	36 0.2×	50	2.0k
Clemens Lange Germany	29	980 1.2×	1.8k 2.5×	421 1.2×	978 3.4×	340 1.9×	109	3.0k
Judit Baffi United States	17	731 0.9×	958 1.3×	311 0.9×	435 1.5×	95 0.5×	24	1.5k
Andrea Santeford United States	19	550 0.7×	390 0.5×	258 0.7×	226 0.8×	119 0.7×	35	1.5k
Zhigang Fan China	19	522 0.6×	492 0.7×	213 0.6×	314 1.1×	83 0.5×	59	1.4k
Hanna Janicki Germany	10	732 0.9×	776 1.1×	149 0.4×	401 1.4×	143 0.8×	12	1.6k

Countries citing papers authored by Bradley D. Gelfand

Since Specialization

Citations

This map shows the geographic impact of Bradley D. Gelfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley D. Gelfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley D. Gelfand more than expected).

Fields of papers citing papers by Bradley D. Gelfand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley D. Gelfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley D. Gelfand. The network helps show where Bradley D. Gelfand may publish in the future.

Co-authorship network of co-authors of Bradley D. Gelfand

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley D. Gelfand. A scholar is included among the top collaborators of Bradley D. Gelfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley D. Gelfand. Bradley D. Gelfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Apicella, Ivana, Shin‐ichi Fukuda, Shuichiro Hirahara, et al.. (2024). Inflammasome activation aggravates choroidal neovascularization. Angiogenesis. 27(4). 919–929. 1 indexed citations

Huang, Peirong, Kameshwari Ambati, Praveen Yerramothu, et al.. (2023). Kamuvudine-9 Protects Retinal Structure and Function in a Novel Model of Experimental Rhegmatogenous Retinal Detachment. Investigative Ophthalmology & Visual Science. 64(5). 3–3. 4 indexed citations

An, Senyou, Huidan Yu, Xiaoyu Zhang, et al.. (2023). Effects of donor-specific microvascular anatomy on hemodynamic perfusion in human choriocapillaris. Scientific Reports. 13(1). 22666–22666. 5 indexed citations

Gelfand, Bradley D., et al.. (2023). Survey of commercial antibodies targeting Y chromosome‐encoded genes. SHILAP Revista de lepidopterología. 2(4). 1 indexed citations

Ambati, Meenakshi, Ivana Apicella, Shao-Bin Wang, et al.. (2021). Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration. Proceedings of the National Academy of Sciences. 118(41). 46 indexed citations

Narendran, Siddharth, Felipe Pereira, Praveen Yerramothu, et al.. (2021). Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration. Signal Transduction and Targeted Therapy. 6(1). 149–149. 18 indexed citations

Shen, Hongtao, Jing Li, Huan Yang, et al.. (2021). TMEM97 ablation aggravates oxidant-induced retinal degeneration. Cellular Signalling. 86. 110078–110078. 15 indexed citations

Gelfand, Bradley D., et al.. (2018). Hemodynamic shear stress in the inner choroid primes endothelium for complement damage. Investigative Ophthalmology & Visual Science. 59(9). 3473–3473. 1 indexed citations

Kerur, Nagaraj, Young‐Hee Kim, Shin‐ichi Fukuda, et al.. (2016). Non-canonical NLRP3 Inflammasome activation in Geographic Atrophy. Investigative Ophthalmology & Visual Science. 57(12). 486–486. 12 indexed citations

10.

Gelfand, Bradley D. & Jayakrishna Ambati. (2016). A Revised Hemodynamic Theory of Age-Related Macular Degeneration. Trends in Molecular Medicine. 22(8). 656–670. 48 indexed citations

11.

Gelfand, Bradley D., Charles B. Wright, Young‐Hee Kim, et al.. (2015). Iron Toxicity in the Retina Requires Alu RNA and the NLRP3 Inflammasome. Cell Reports. 11(11). 1686–1693. 70 indexed citations

12.

Mizutani, Takeshi, Benjamin J. Fowler, Young‐Hee Kim, et al.. (2015). Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice. Investigative Ophthalmology & Visual Science. 56(12). 7122–7122. 30 indexed citations

13.

Yasuma, Reo, Sasha Bogdanovich, Young‐Hee Kim, et al.. (2014). Intravenous immunoglobulin treatment inhibits choroidal and corneal neovascularization via FcyR1. Investigative Ophthalmology & Visual Science. 55(13). 1190–1190. 1 indexed citations

14.

Gelfand, Bradley D., Yoshio Hirano, Tetsuhiro Yasuma, et al.. (2014). IL18 is not therapeutic for neovascular age-related macular degeneration. Investigative Ophthalmology & Visual Science. 55(13). 3553–3553. 1 indexed citations

15.

Wright, Charles B., Young‐Hee Kim, Tetsuhiro Yasuma, et al.. (2014). Enhanced Alu RNA stability due to iron-mediated DICER1 impairment causes NLRP3 inflammasome priming. Investigative Ophthalmology & Visual Science. 55(13). 2187–2187. 1 indexed citations

16.

Feaver, Ryan E., Bradley D. Gelfand, & Brett R. Blackman. (2013). Human haemodynamic frequency harmonics regulate the inflammatory phenotype of vascular endothelial cells. Nature Communications. 4(1). 1525–1525. 81 indexed citations

17.

Dridi, Sami, Hiroki Kaneko, Valeria Tarallo, et al.. (2011). Dicer Dysregulation Induces Cytotoxic Alu Rna Accumulation In Age-related Macular Degeneration. Investigative Ophthalmology & Visual Science. 52(14). 2349–2349. 1 indexed citations

18.

Feaver, Ryan E., Bradley D. Gelfand, Chong Wang, Martin A. Schwartz, & Brett R. Blackman. (2010). Atheroprone Hemodynamics Regulate Fibronectin Deposition to Create Positive Feedback That Sustains Endothelial Inflammation. Circulation Research. 106(11). 1703–1711. 103 indexed citations

19.

Harry, Brian L., John M. Sanders, Ryan E. Feaver, et al.. (2008). Endothelial Cell PECAM-1 Promotes Atherosclerotic Lesions in Areas of Disturbed Flow in ApoE-Deficient Mice. Arteriosclerosis Thrombosis and Vascular Biology. 28(11). 2003–2008. 114 indexed citations

20.

Gelfand, Bradley D., Frederick H. Epstein, & Brett R. Blackman. (2006). Spatial and spectral heterogeneity of time‐varying shear stress profiles in the carotid bifurcation by phase‐contrast MRI. Journal of Magnetic Resonance Imaging. 24(6). 1386–1392. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact